Phytotherapeutic Potential of Lawsonia inermis and Juglans regia in Dermatologic Care: Enhancing Patient Adherence and Outcomes through Community Pharmacy Practice

Session

Pharmaceutical and Natural Sciences

Description

Eczema and superficial mycoses are common, chronic dermatologic conditions that affect quality of life. Conventional therapies may cause side effects and resistance. This prospective observational study evaluated a topical emulsion containing Lawsonia inermis and Juglans regia in a community pharmacy with pharmacist-led interventions. Seventy-three adults applied the emulsion for up to 21 days. Significant improvements in erythema, scaling, and pruritus were observed, particularly in cases of chronic eczema. No adverse events occurred. Pharmacist counseling improved adherence and reduced corticosteroid use. These findings highlight the therapeutic potential of phytotherapeutics and emphasize the evolving role of community pharmacists. Further randomized trials are warranted.

Keywords:

Phytotherapy, Lawsonia inermis, Juglans regia, eczema, superficial mycoses, pharmacist interventions, patient adherence

Proceedings Editor

Edmond Hajrizi

ISBN

978-9951-982-41-2

Location

UBT Lipjan, Kosovo

Start Date

25-10-2025 9:00 AM

End Date

26-10-2025 6:00 PM

DOI

10.33107/ubt-ic.2025.346

This document is currently not available here.

Share

COinS
 
Oct 25th, 9:00 AM Oct 26th, 6:00 PM

Phytotherapeutic Potential of Lawsonia inermis and Juglans regia in Dermatologic Care: Enhancing Patient Adherence and Outcomes through Community Pharmacy Practice

UBT Lipjan, Kosovo

Eczema and superficial mycoses are common, chronic dermatologic conditions that affect quality of life. Conventional therapies may cause side effects and resistance. This prospective observational study evaluated a topical emulsion containing Lawsonia inermis and Juglans regia in a community pharmacy with pharmacist-led interventions. Seventy-three adults applied the emulsion for up to 21 days. Significant improvements in erythema, scaling, and pruritus were observed, particularly in cases of chronic eczema. No adverse events occurred. Pharmacist counseling improved adherence and reduced corticosteroid use. These findings highlight the therapeutic potential of phytotherapeutics and emphasize the evolving role of community pharmacists. Further randomized trials are warranted.